InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,064.20
(
0.91%
)
US TECH 100
17,157.20
(
1.76%
)
Dow Jones
38,225.66
(
0.85%
)
Brent Oil
83.63
(
0.11%
)
Bitcoin
59,383.39
(
1.96%
)
Post# of 29871
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

BlazingStocks

Send PM Follow Ignore
Followers 167
Posts 35814
Boards Moderated 4
Alias Born 10/20/2019

BlazingStocks

Member Level

Re: ProfitScout post# 29814

Wednesday, 02/14/2024 3:39:41 PM

Wednesday, February 14, 2024 3:39:41 PM

Post# of 29871
$NRXP - Alvogen and Lotus will be responsible for future development and commercialization costs for NRX-101 in treatment of bipolar depression with suicidality.
https://finance.yahoo.com/news/nrx-pharmaceuticals-inc-nasdaq-nrxp-133000063.html
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up